Key result
Extremely low HDL-C is often linked to biochemical abnormalities or analytical assay interference.
Why the study?
Extremely low HDL-C levels (<10 mg/dL) are rarely observed and may result from severe metabolic disorders, genetic conditions, or analytical interferences, requiring better understanding for accurate interpretation.
Observational (n=1,022,234)
Yes
Extremely low HDL-C (< 10 mg/dL) is a rare laboratory finding (0.015% prevalence) that is often associated with severe biochemical abnormalities or preanalytical interferences rather than isolated genetic lipid disorders.
BACKGROUND: Extremely low levels of high-density lipoprotein cholesterol (HDL-C), defined as < 10 mg/dL, are rarely observed in clinical laboratories and may result from severe metabolic disorders, genetic conditions, or analytical and preanalytical interferences. Understanding the prevalence and associated findings of such results is critical for accurate interpretation. METHODS: We retrospectively analyzed 1,022,234 HDL-C test results from specimens submitted to GC Labs, a large referral laboratory in South Korea, between January and December 2023. For specimens with HDL-C < 10 mg/dL, concurrent laboratory findings were evaluated. Additional comparisons of the prevalence of HDL-C < 10 mg/dL and its associated laboratory findings were made using public datasets from KNHANES (2011 - 2023), NHIS (2023), and US NHANES (2015 - 2020). RESULTS: Among all specimens, 147 (0.015%) showed HDL-C < 10 mg/dL. Out of these, 125 specimens had available concurrent test results. Common findings included abnormal liver chemistries (56.8%), decreased kidney function (31.2%), elevated CRP (20.0%), anemia, and very high triglyceride levels (≥ 500 mg/dL in 33.6%). Several patterns suggested preanalytical issues, including delayed serum separation, dilutional effects, or lipemic interference observed on gross examination (12.0%). One case showed no apparent abnormalities, raising suspicion of rare genetic or medical conditions or analytical error. Public datasets showed similarly low prevalence (0.004 - 0.009%) and comparable findings. CONCLUSIONS: Extremely low HDL-C values are rare but often linked to identifiable biochemical abnormalities or preanalytical/analytical interferences. Reviewing concurrent test results and specimen handling helps distinguish true pathology from spurious results and improve diagnostic accuracy in clinical laboratories.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2026) conducted an observational in Extremely low high-density lipoprotein cholesterol (n=1,022,234). Extremely low HDL-C (< 10 mg/dL) was evaluated on Prevalence of HDL-C < 10 mg/dL. Extremely low HDL-C (< 10 mg/dL) was observed in 0.015% of specimens and was frequently linked to abnormal liver chemistries, decreased kidney function, or preanalytical interferences.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: